United Therapeutics Profit Margin

United Therapeutics (UTHR) currently reports a profit margin of 41.56% as of June 2026. That compares with 40.36% in the prior-year period — up 3.0% year over year. That is above the Healthcare sector average of 21.34%. Use the charts on this page to explore United Therapeutics's profit margin history and peer comparisons.

United Therapeutics's profit margin increased from 40.36% to 41.56% — a 3.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

United Therapeutics's profit margin of 41.56% is higher than the Healthcare sector average of 21.34%. That is roughly 94.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but United Therapeutics's current 41.56% should be judged against Healthcare norms (sector average: 21.34%) and against UTHR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 41.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for United Therapeutics, and consider following UTHR for alerts when major investors trade the stock.